Poly(ADP-ribose) polymerase in DNA damage-response pathway: Implications for radiation oncology

被引:0
|
作者
Soldatenkov, VA
Smulson, M
机构
[1] Georgetown Univ, Sch Med, Dept Radiat Med, Div Radiat Res, Washington, DC 20007 USA
[2] Georgetown Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC USA
关键词
poly(ADP-ribose) polymerase; ionizing radiation; DNA damage repair; cell death; gene regulation;
D O I
10.1002/(SICI)1097-0215(20000420)90:2<59::AID-IJC1>3.0.CO;2-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Poly(ADP-ribose) polymerase (PARP) catalyzes the transfer of successive units of ADP-ribose moiety from NAD(+) covalently to itself and other nuclear acceptor proteins. PARP is a zinc finger-containing protein, allowing the enzyme to bind to either double- or single-strand DNA breaks without any apparent sequence preference. The catalytic activity of PARP is strictly dependent on the presence of strand breaks in DNA and is modulated by the level of automodification, Data from many studies show that PARP is involved in numerous biological functions, all of which are associated with the breaking and rejoining of DNA strands, and plays a pivotal role in DNA damage repair. Recent advances in apoptosis research identified PARP as one of the intracellular "death substrates" and demonstrated the involvement of polymerase in the execution of programmed cell death. This review summarizes the biological effects of PARP function that may have a potential for targeted sensitization of tumor cells to genotoxic agents and radiotherapy. Int. J. Cancer (Radiat. Oncol. Invest.) 90, 59-67 (2000). (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:59 / 67
页数:9
相关论文
共 50 条
  • [21] DNA-binding properties of poly(ADP-ribose) polymerase: A target for anticancer therapy
    Soldatenkov, VA
    Potaman, VN
    CURRENT DRUG TARGETS, 2004, 5 (04) : 357 - 365
  • [22] Proteomic Investigation of Phosphorylation Sites in Poly(ADP-ribose) Polymerase-1 and Poly(ADP-ribose) Glycohydrolase
    Gagne, Jean-Philippe
    Moreel, Xavier
    Gagne, Pierre
    Labelle, Yves
    Droit, Arnaud
    Chevalier-Pare, Melissa
    Bourassa, Sylvie
    McDonald, Darin
    Hendzel, Michael J.
    Prigent, Claude
    Poirier, Guy G.
    JOURNAL OF PROTEOME RESEARCH, 2009, 8 (02) : 1014 - 1029
  • [23] PARP2 Is the Predominant Poly(ADP-Ribose) Polymerase in Arabidopsis DNA Damage and Immune Responses
    Song, Junqi
    Keppler, Brian D.
    Wise, Robert R.
    Bent, Andrew F.
    PLOS GENETICS, 2015, 11 (05):
  • [24] Response of Dictyostelium discoideum to UV-C and involvement of poly (ADP-ribose) polymerase
    Mir, H.
    Alex, T.
    Rajawat, J.
    Kadam, A.
    Begum, R.
    CELL PROLIFERATION, 2015, 48 (03) : 363 - 374
  • [25] Nitric oxide-peroxynitrite-poly(ADP-ribose) polymerase pathway in the skin
    Virág, L
    Szabó, É
    Bakondi, E
    Bai, P
    Gergely, P
    Hunyadi, J
    Szabó, C
    EXPERIMENTAL DERMATOLOGY, 2002, 11 (03) : 189 - 202
  • [26] Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation
    Besson, Valerie C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (05) : 695 - 704
  • [27] Poly (ADP-ribose) polymerase inhibitors in cancer therapy
    Zhu, Ziqi
    Shi, Yujun
    CHINESE MEDICAL JOURNAL, 2025, 138 (06) : 634 - 650
  • [28] INACTIVATION OF POLY(ADP-RIBOSE) POLYMERASE BY HYPOCHLOROUS ACID
    VANRENSBURG, CEJ
    VANSTADEN, AM
    ANDERSON, R
    FREE RADICAL BIOLOGY AND MEDICINE, 1991, 11 (03) : 285 - 291
  • [29] STRUCTURAL REQUIREMENTS FOR INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE
    SESTILI, P
    SPADONI, G
    BALSAMINI, C
    SCOVASSI, I
    CATTABENI, F
    DURANTI, E
    CANTONI, O
    HIGGINS, D
    THOMSON, C
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1990, 116 (06) : 615 - 622
  • [30] Cardioprotective effects of poly (ADP-ribose) polymerase inhibition
    Szabó, C
    PHARMACOLOGICAL RESEARCH, 2005, 52 (01) : 34 - 43